{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:04:08Z","timestamp":1793318648287,"version":"4.5.0"},"reference-count":79,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T00:00:00Z","timestamp":1476230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["280873"],"award-info":[{"award-number":["280873"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["241904"],"award-info":[{"award-number":["241904"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Vaccines have successfully eradicated a large number of diseases. However, some infectious diseases (such as HIV, Chlamydia trachomatis or Bacillus anthracis) keep spreading since there is no vaccine to prevent them. One way to overcome this issue is the development of new adjuvant formulations which are able to induce the appropriate immune response without sacrificing safety. Lymph nodes are the site of lymphocyte priming by antigen-presenting cells and subsequent adaptive immune response, and are a promising target for vaccine formulations. In this review, we describe the properties of different polymer-based (e.g., poly lactic-co-glycolic acid, poly lactic acid \u2026) particulate adjuvants as innovative systems, capable of co-delivering immunopotentiators and antigens. We point out how these nanoparticles enhance the delivery of antigens, and how their physicochemical properties modify their uptake by antigen-presenting cells and their migration into lymph nodes. We describe why polymeric nanoparticles increase the persistence into lymph nodes and promote a mature immune response. We also emphasize how nanodelivery directs the response to a specific antigen and allows the induction of a cytotoxic immune response, essential for the fight against intracellular pathogens or cancer. Finally, we highlight the interest of the association between polymer-based vaccines and immunopotentiators, which can potentiate the effect of the molecule by directing it to the appropriate compartment and reducing its toxicity.<\/jats:p>","DOI":"10.3390\/vaccines4040034","type":"journal-article","created":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T10:18:49Z","timestamp":1476267529000},"page":"34","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":135,"title":["Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting"],"prefix":"10.3390","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7000-1090","authenticated-orcid":false,"given":"Alice","family":"Gutjahr","sequence":"first","affiliation":[{"name":"Laboratoire de Biologie Tissulaire et d\u2019Ing\u00e9nierie Th\u00e9rapeutique, UMR 5305, Universit\u00e9 Lyon 1, CNRS, IBCP, Lyon 69007, France"},{"name":"InvivoGen, Toulouse 31400, France"},{"name":"Groupe Immunit\u00e9 des Muqueuses et Agents Pathog\u00e8nes, INSERM CIC1408 Vaccinologie, Facult\u00e9 de M\u00e9decine de Saint-Etienne, Saint-Etienne 42270, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7803-505X","authenticated-orcid":false,"given":"Capucine","family":"Phelip","sequence":"additional","affiliation":[{"name":"Laboratoire de Biologie Tissulaire et d\u2019Ing\u00e9nierie Th\u00e9rapeutique, UMR 5305, Universit\u00e9 Lyon 1, CNRS, IBCP, Lyon 69007, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4069-8629","authenticated-orcid":false,"given":"Anne-Line","family":"Coolen","sequence":"additional","affiliation":[{"name":"Laboratoire de Biologie Tissulaire et d\u2019Ing\u00e9nierie Th\u00e9rapeutique, UMR 5305, Universit\u00e9 Lyon 1, CNRS, IBCP, Lyon 69007, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Monge","sequence":"additional","affiliation":[{"name":"Laboratoire de Biologie Tissulaire et d\u2019Ing\u00e9nierie Th\u00e9rapeutique, UMR 5305, Universit\u00e9 Lyon 1, CNRS, IBCP, Lyon 69007, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8436-958X","authenticated-orcid":false,"given":"Anne-Sophie","family":"Boisgard","sequence":"additional","affiliation":[{"name":"Laboratoire de Biologie Tissulaire et d\u2019Ing\u00e9nierie Th\u00e9rapeutique, UMR 5305, Universit\u00e9 Lyon 1, CNRS, IBCP, Lyon 69007, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Paul","sequence":"additional","affiliation":[{"name":"Groupe Immunit\u00e9 des Muqueuses et Agents Pathog\u00e8nes, INSERM CIC1408 Vaccinologie, Facult\u00e9 de M\u00e9decine de Saint-Etienne, Saint-Etienne 42270, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Verrier","sequence":"additional","affiliation":[{"name":"Laboratoire de Biologie Tissulaire et d\u2019Ing\u00e9nierie Th\u00e9rapeutique, UMR 5305, Universit\u00e9 Lyon 1, CNRS, IBCP, Lyon 69007, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,10,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","article-title":"Smallpox vaccines\u202f: Targets of protective immunity","volume":"239","author":"Moss","year":"2012","journal-title":"Immunol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.smim.2010.04.007","article-title":"Seminars in Immunology Adjuvants for cancer vaccines","volume":"22","author":"Dubensky","year":"2010","journal-title":"Semin. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1016\/j.vaccine.2012.08.023","article-title":"Nanovaccinology: The next generation of vaccines meets 21st century materials science and engineering","volume":"30","author":"Mamo","year":"2012","journal-title":"Vaccine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1163\/156856206775997322","article-title":"Synthesis and characterization of PLGA nanoparticles","volume":"17","author":"Astete","year":"2006","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1208\/s12248-012-9418-6","article-title":"Biodegradable particles as vaccine delivery systems: Size matters","volume":"15","author":"Joshi","year":"2013","journal-title":"AAPS J."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Mahapatro, A., and Singh, D.K. (2011). Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J. Nanobiotechnol.","DOI":"10.1186\/1477-3155-9-55"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/vaccines3040930","article-title":"From Antigen Delivery System to Adjuvanticy: The Board Application of Nanoparticles in Vaccinology","volume":"3","author":"Boraschi","year":"2015","journal-title":"Vaccines"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4161\/hv.26796","article-title":"Polymeric nanoparticles Potent vectors for vaccine delivery targeting cancer and infectious diseases","volume":"10","author":"Bolhassani","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/btm2.10003","article-title":"Nanoparticles in the Clinic","volume":"55","author":"Anselmo","year":"2016","journal-title":"Bioeng. Transl. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Moon, J.J., Suh, H., Polhemus, M.E., Ockenhouse, C.F., Yadava, A., and Irvine, D.J. (2012). Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccine. PLoS ONE.","DOI":"10.1371\/journal.pone.0031472"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.vaccine.2005.10.021","article-title":"Immunological responses after immunisation of mice with microparticles containing antigen and single stranded RNA (polyuridylic acid)","volume":"24","author":"Westwood","year":"2006","journal-title":"Vaccine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1016\/j.biomaterials.2007.08.015","article-title":"Interactions of antigen-loaded polylactide particles with macrophages and their correlation with the immune response","volume":"28","author":"Kanchan","year":"2007","journal-title":"Biomaterials"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.nano.2014.02.009","article-title":"Poly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in mice","volume":"10","author":"Dixit","year":"2014","journal-title":"Nanomed. Nanotech. Biol. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.vaccine.2011.10.105","article-title":"PLGA\/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmo salar L.)","volume":"30","author":"Fredriksen","year":"2012","journal-title":"Vaccine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1016\/j.biomaterials.2010.04.021","article-title":"Traffic of poly(lactic acid) nanoparticulate vaccine vehicle from intestinal mucus to sub-epithelial immune competent cells","volume":"31","author":"Primard","year":"2010","journal-title":"Biomaterials"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jconrel.2010.07.116","article-title":"Polymer particle shape independently influences binding and internalization by macrophages","volume":"147","author":"Sharma","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jconrel.2013.01.015","article-title":"Encapsulation of Nod1 and Nod2 receptor ligands into poly(lactic acid) nanoparticles potentiates their immune properties","volume":"167","author":"Pavot","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.01.044","article-title":"Poly-\u03b5-caprolactone microspheres and nanospheres: An overview","volume":"278","author":"Sinha","year":"2004","journal-title":"Int. J. Pharm."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jconrel.2013.03.010","article-title":"Immune system targeting by biodegradable nanoparticles for cancer vaccines","volume":"168","author":"Silva","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/12_2011_150","article-title":"Biodegradable Nanoparticles as Vaccine Adjuvants and Delivery Systems: Regulation of Immune Responses by Nanoparticle-Based Vaccine","volume":"247","author":"Akagi","year":"2012","journal-title":"Adv. Polym. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1016\/j.vaccine.2004.11.052","article-title":"Mucosal targeting of allergen-loaded microspheres by Aleuria aurantia lectin","volume":"23","author":"Untersmayr","year":"2005","journal-title":"Vaccine"},{"key":"ref_23","unstructured":"M\u00e9ndez-Vilas, A. (2013). Microbial Pathogens and Strategies for Combating Them: Science Technolgy and Education."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1586\/erv.11.126","article-title":"The long-term potential of biodegradable poly(lactideco-glycolide) microparticles as the next-generation vaccine adjuvant","volume":"10","author":"Jain","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of Dendritic Cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1124\/pr.111.005363","article-title":"Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles","volume":"64","author":"Morachis","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1021\/bm101482r","article-title":"Surface Charge Affects Cellular Uptake and Intracellular Trafficking of Chitosan-Based Nanoparticles","volume":"12","author":"Yue","year":"2011","journal-title":"Biomacromolecules"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/pr.58.1.8","article-title":"Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery","volume":"58","author":"Khalil","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymeth.2006.05.016","article-title":"Pathogen recognition and development of particulate vaccines: Does size matter?","volume":"40","author":"Scholzen","year":"2006","journal-title":"Methods"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2006.01.006","article-title":"In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles","volume":"112","author":"Reddy","year":"2006","journal-title":"J. Control. Release"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.vaccine.2014.12.059","article-title":"Poly-(lactic-co-glycolic-acid)-based particulate vaccines: Particle uptake by dendritic cells is a key parameter for immune activation","volume":"33","author":"Silva","year":"2015","journal-title":"Vaccine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/adhm.201200268","article-title":"Micro and nanoparticle-based delivery systems for vaccine immunotherapy: An immunological and materials perspective","volume":"2","author":"Leleux","year":"2013","journal-title":"Adv. Healthc. Mater."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.4161\/hv.26136","article-title":"Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses","volume":"912","author":"Joshi","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/wnan.1348","article-title":"Shaping the future of nanomedicine: Anisotropy in polymeric nanoparticle design","volume":"8","author":"Meyer","year":"2016","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1073\/pnas.0600997103","article-title":"Role of target geometry in phagocytosis","volume":"103","author":"Champion","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nnano.2007.70","article-title":"Shape effects of filaments versus spherical particles in flow and drug delivery","volume":"2","author":"Geng","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jconrel.2010.04.007","article-title":"Flow and adhesion of drug carriers in blood vessels depend on their shape: A study using model synthetic microvascular networks","volume":"146","author":"Doshi","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3109\/17435390.2013.773465","article-title":"Surface functionalization affects the zeta potential, coronal stability and membranolytic activity of polymeric nanoparticles","volume":"8","author":"Cho","year":"2014","journal-title":"Nanotoxicology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/jbm.a.32860","article-title":"Surface modification of poly(d,l-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells","volume":"96","author":"Han","year":"2011","journal-title":"J. Biomed. Mater. Res. A"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Petrizzo, A., Conte, C., Tagliamonte, M., Napolitano, M., Bifulco, K., Carriero, V., De Stradis, A., Tornesello, M.L., Buonaguro, F.M., and Quaglia, F. (2015). Functional characterization of biodegradable nanoparticles as antigen delivery system. J. Exp. Clin. Cancer Res.","DOI":"10.1186\/s13046-015-0231-9"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/imr.12432","article-title":"Dendritic cell maturation and cross-presentation\u202f: Timing matters\u202f!","volume":"272","author":"Alloatti","year":"2016","journal-title":"Immunol. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2006.07.006","article-title":"Coadsorption of HIV-1 p24 and gp120 proteins to surfactant-free anionic PLA nanoparticles preserves antigenicity and immunogenicity","volume":"115","author":"Munier","year":"2006","journal-title":"J. Control. Release"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri3254","article-title":"Cross-presentation by dendritic cells","volume":"12","author":"Joffre","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_46","first-page":"5231","article-title":"Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigen","volume":"9","author":"Saluja","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1016\/j.biomaterials.2012.03.041","article-title":"Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype","volume":"33","author":"Demento","year":"2012","journal-title":"Biomaterials"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1016\/j.vaccine.2010.09.077","article-title":"Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation","volume":"28","author":"Hirosue","year":"2010","journal-title":"Vaccine"},{"key":"ref_49","first-page":"449","article-title":"Materials engineering for immunomodulation","volume":"462","author":"Hubbell","year":"2009","journal-title":"Nat. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.284.5418.1313","article-title":"Phylogenetic Perspectives in Innate Immunity","volume":"284","author":"Hoffmann","year":"1999","journal-title":"Science"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.it.2016.07.001","article-title":"Triggering Intracellular Receptors for Vaccine Adjuvantation","volume":"37","author":"Gutjahr","year":"2016","journal-title":"Trends Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappa B by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.coi.2016.06.007","article-title":"The science of vaccine adjuvants: Advances in TLR4 ligand adjuvants","volume":"41","author":"Reed","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.addr.2007.11.004","article-title":"Recognition of viral single-stranded RNA by Toll-like receptors","volume":"60","author":"Diebold","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.4049\/jimmunol.1402755","article-title":"Minimal Sequence Requirements for Minimal Sequence Requirements for Oligodeoxyribonucleotides Activating Human TLR9","volume":"194","author":"Pohar","year":"2015","journal-title":"J Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00024382-200212000-00013","article-title":"Removal of phosphate from lipid A as a strategy to detoxify lipopolysaccharide","volume":"18","author":"Bentala","year":"2002","journal-title":"Shock"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpb.2016.05.018","article-title":"PLGA nanoparticles modified with a TNFa mimicking peptide, soluble Leishmania antigens and MPLA induce T cell priming in vitro via dendritic cell functional differentiation","volume":"105","author":"Margaroni","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jconrel.2012.06.034","article-title":"Potential of NOD receptor ligands as immunomodulators in particulate vaccine carriers","volume":"164","author":"Wischke","year":"2012","journal-title":"J. Control Release"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1016\/j.vaccine.2008.07.035","article-title":"Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity","volume":"26","author":"Hamdy","year":"2008","journal-title":"Vaccine"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jconrel.2012.06.015","article-title":"Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice","volume":"162","author":"Mueller","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2015.02.006","article-title":"Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation","volume":"203","author":"Rahimian","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.1182\/blood-2011-07-367615","article-title":"Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity","volume":"118","author":"Tacken","year":"2011","journal-title":"Blood"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1126\/scitranslmed.3008068","article-title":"Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205","volume":"6","author":"Dhodapkar","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2014.07.040","article-title":"Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8+ T cell response: A comparative study","volume":"192","author":"Cruz","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biomaterials.2016.03.039","article-title":"Artificial bacterial biomimetic nanoparticles synergize pathogen- associated molecular patterns for vaccine efficacy","volume":"97","author":"Siefert","year":"2016","journal-title":"Biomaterials"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"Kasturi","year":"2011","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"19902","DOI":"10.1073\/pnas.1313152110","article-title":"Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose","volume":"110","author":"Ballester","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/nbt.3371","article-title":"In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity","volume":"33","author":"Lynn","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/j.vaccine.2014.02.027","article-title":"Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release","volume":"32","author":"Ilyinskii","year":"2014","journal-title":"Vaccine"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1172\/JCI79915","article-title":"Nanoparticulate STING agonists are potent lymph node\u2014targeted vaccine adjuvants","volume":"125","author":"Hanson","year":"2015","journal-title":"J. Clin. Invest."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/eji.200737169","article-title":"Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity","volume":"37","author":"Heit","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1021\/bc300611b","article-title":"Synergistic stimulation of antigen presenting cells via tlr by combining CpG ODN and Poly(g-glutamic acid)-based nanoparticles as vaccine adjuvants","volume":"24","author":"Shima","year":"2013","journal-title":"Bioconjug. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2016.05.013","article-title":"The preparation and characterization of PLG nanoparticles with an entrapped synthetic TLR7 agonist and their preclinical evaluation as adjuvant for an adsorbed DTaP vaccine","volume":"105","author":"Bruno","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.4049\/jimmunol.1000768","article-title":"TLR9-Targeted Biodegradable Nanoparticles as Immunization Vectors Protect against West Nile Encephalitis","volume":"185","author":"Demento","year":"2010","journal-title":"J. Immunol."},{"key":"ref_76","first-page":"97","article-title":"Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(d,l-lactic-co-glycolic acid) nanoparticles","volume":"33","author":"Hamdy","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4110\/in.2013.13.1.30","article-title":"Induction of Potent Antigen-specific Cytotoxic T Cell Response by PLGA-nanoparticles Containing Antigen and TLR Agonist","volume":"13","author":"Lee","year":"2013","journal-title":"Immune. Netw."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2014.11.033","article-title":"In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model","volume":"198","author":"Silva","year":"2015","journal-title":"J. Control. Release"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1080\/10611860903119656","article-title":"Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response","volume":"17","author":"Fischer","year":"2009","journal-title":"J. Drug Target."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/4\/4\/34\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:32:45Z","timestamp":1760211165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/4\/4\/34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,12]]},"references-count":79,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,12]]}},"alternative-id":["vaccines4040034"],"URL":"https:\/\/doi.org\/10.3390\/vaccines4040034","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,12]]}}}